- Home
- EYE vs RXRX Comparison
EYE vs RXRX Comparison
Compare EYE & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYE
- RXRX
- Stock Information
- Founded
- EYE 1990
- RXRX 2013
- Country
- EYE United States
- RXRX United States
- Employees
- EYE N/A
- RXRX N/A
- Industry
- EYE Ophthalmic Goods
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- EYE Health Care
- RXRX Health Care
- Exchange
- EYE Nasdaq
- RXRX Nasdaq
- Market Cap
- EYE 2.0B
- RXRX 2.2B
- IPO Year
- EYE 2017
- RXRX 2021
- Fundamental
- Price
- EYE $24.81
- RXRX $4.08
- Analyst Decision
- EYE Buy
- RXRX Buy
- Analyst Count
- EYE 9
- RXRX 4
- Target Price
- EYE $25.67
- RXRX $7.25
- AVG Volume (30 Days)
- EYE 1.9M
- RXRX 37.0M
- Earning Date
- EYE 11-05-2025
- RXRX 11-05-2025
- Dividend Yield
- EYE N/A
- RXRX N/A
- EPS Growth
- EYE N/A
- RXRX N/A
- EPS
- EYE N/A
- RXRX N/A
- Revenue
- EYE $1,921,355,000.00
- RXRX $43,689,000.00
- Revenue This Year
- EYE $8.59
- RXRX $24.17
- Revenue Next Year
- EYE $3.59
- RXRX $20.96
- P/E Ratio
- EYE N/A
- RXRX N/A
- Revenue Growth
- EYE 6.33
- RXRX N/A
- 52 Week Low
- EYE $9.93
- RXRX $3.79
- 52 Week High
- EYE $29.60
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- EYE 46.66
- RXRX 33.34
- Support Level
- EYE $22.83
- RXRX $3.96
- Resistance Level
- EYE $25.79
- RXRX $4.80
- Average True Range (ATR)
- EYE 1.38
- RXRX 0.34
- MACD
- EYE 0.01
- RXRX -0.12
- Stochastic Oscillator
- EYE 57.26
- RXRX 6.39
About EYE National Vision Holdings Inc.
National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.